Monash Health

Melbourne, Victoria 3168

0 studies enrolling now · 6 studies all time

What they study most

Acute Myeloid Leukemia (AML), Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Chronic Myelomonocytic Leukemia (CMML), Diffuse Large B-cell Lymphoma (DLBCL), HER2-positive Advanced Solid Tumor, Hepatocellular Carcinoma, Lupus Nephritis, MDS/Myeloproliferative Neoplasm (MPN) Overlap Syndrome, Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma, Metastatic Colon Cancer

Studies at this site

• A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors — Recruiting now
• A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer — Completed
• A Study to Learn More About the Safety and Effects of Felzartamab in Adults With Lupus Nephritis Aged 18 to 75 Years Old — Completed
• A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma — Running, not enrolling
• A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies — Completed
• A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer — Completed